A recent study shows that the administration of a short vaccination regimen with an anti-HER2 dendritic cell vaccine consisting partly of their own cells led to complete tumor destruction in nearly 20% of women with ductal carcinoma in situ.
Erivedge is a first-in-class hedgehog pathway inhibitor that aids in minimizing disfiguring or potentially life-threatening advanced skin cancer lesions
A national fast track system for cancer patients that was implemented in Denmark reduced the time between a patient’s initial meeting with a healthcare provider and their first treatment.
The drug dutasteride delays both cancer progression and the start of active treatment for men diagnosed with low-risk, localized prostate cancer, according to results from a 3-year international clinical trial.
According to 2 recent studies, a new investigational colorectal cancer screening test is highly sensitive and more accurate at detecting adenomas and early-stage cancer compared with other noninvasive tests.
The carpal tunnel syndrome side effect from a medication found to reduce women’s risk of death from breast cancer can be managed and does not persist upon completed treatment, according to a study published in The Lancet Oncology.
The recent drop in melanoma mortality rates among non-Hispanic whites in the US is found among those patients with higher levels of education, according to a new study from the American Cancer Society.
Stage III colon cancer patients experience an increased rate of survival when oxaliplatin is combined with 5-fluorouracil (5-FU) during adjuvant treatment, according to a study published in the Journal of the National Cancer Institute.
